- In charge of the sales, business development and lead generation for Spain, Europe and International regions. - Gross annual revenue reached at +300k EUR for 2023 and achieving +400k EUR for 2024. Goal for 2025 established at +500k. - Participated in a National trade mission initiative to North Carolina partnering with major key players within the government and academic institutions like: NCbiotech, First Flight Ventures, Wake Forest University, East Carolina University and North Carolina State University. - Analytical services offered: DS/DP Characterization, Impurities & Nitrosamines Studies, Pre-clinical Studies (In-Vitro, In-Vivo, PK/PD), Host Cell Protein Analysis, Extractables and Leachables Studies, Residuals Determination, Endotoxins, Microbial burden & Viral Safety, Sterility assurance, Metabolomics, Lipidomics & Proteomics, Stability Studies, Standards Purification and Synthesis. - Molecular targets studied: Inorganic Impurities, Heavy Metals, Organic Impurities: Amino Acids, Peptides, Glycans & Proteins, Monoclonal Antibodies & ADCs, Oligonucleotides, Plasmids, RNAs & DNAs, and a wide range of metabolic biomarkers. - Reported to: Sales Director, CEO.